Exploring G Protein-Coupled Receptors in Hematological Cancers
Choi Har Tsang1, Pawel Kozielewicz1
1Molecular Pharmacology of GPCRs, Department Physiology & Pharmacology, Karolinska Institutet, Biomedicum, 171 65 Stockholm, Sweden.
ACS Pharmacology & Translational Science
|December 19, 2024
Summary
This study reveals distinct G protein-coupled receptor (GPCR) expression profiles in pediatric acute lymphoblastic leukemia (ALL). Aberrantly expressed GPCRs like GPR85, GPR65, and GPR183 may offer new therapeutic targets for childhood leukemia.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hematological cancers, including lymphomas and leukemias, present complex challenges in cancer treatment.
- Understanding the molecular mechanisms driving these diseases is crucial for developing effective therapies.
- G protein-coupled receptors (GPCRs) are implicated in various cellular processes and cancer development.
Purpose of the Study:
- To investigate the role of GPCRs in hematological malignancies, with a specific focus on pediatric acute lymphoblastic leukemia (ALL).
- To identify novel GPCRs with aberrant expression in pediatric ALL and explore their potential as therapeutic targets.
Main Methods:
- RNA sequencing (RNA-seq) was employed to analyze GPCR expression patterns in pediatric ALL samples.
- Focus was placed on Class A orphan GPCRs.
- Missense mutations in pediatric ALL were analyzed in conjunction with RNA gene expression data.
Main Results:
- Distinct GPCR expression profiles were identified in pediatric ALL samples compared to healthy controls.
- Several GPCRs, including GPR85, GPR65, and GPR183, showed aberrant upregulation.
- Analysis provided insights into the genetic underpinnings by correlating RNA-seq and missense mutation data.
Conclusions:
- GPCRs exhibit unique expression patterns in pediatric ALL, suggesting their involvement in the disease's pathogenesis.
- Aberrantly expressed GPCRs represent potential biomarkers and therapeutic targets for pediatric ALL.
- Integrating expression and mutation data offers a comprehensive view of GPCR roles in pediatric ALL.
More Related Videos
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
9.9K
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
13.6K
Related Concept Videos
01:15G Protein-coupled Receptors
11.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.3K
01:28Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
01:21G-protein Coupled Receptors
115.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
115.9K
01:30Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K